Targeted metabolomics

Current Protocols in Molecular Biology

Volumn 1, Issue SUPPL.98, 2012, Pages

  Roberts, Lee D ^a   Souza, Amanda L ^b   Gerszten, Robert E ^a,b   Clish, Clary B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Liquid chromatography mass spectrometry; Multiple reaction monitoring; Targeted metabolomics

Indexed keywords

ACCURACY; ARTICLE; CLINICAL PROTOCOL; EXPERIMENTAL DESIGN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; METABOLITE; METABOLOME; METABOLOMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS MONITORING; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; STRATEGIC PLANNING; ANIMAL; CHEMISTRY; HUMAN; METHODOLOGY; PLASMA;

ANIMALS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PLASMA;

EID: 84864076985     PISSN: 19343639     EISSN: 19343647     Source Type: Journal    
DOI: 10.1002/0471142727.mb3002s98     Document Type: Article

References (41)

1. An, J., Muoio, D.M., Shiota, M., Fujimoto, Y., Cline, G.W., Shulman, G.I., Koves, T.R., Stevens, R., Millington, D., and Newgard, C.B. 2004. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and wholeanimal insulin resistance. Nat. Med. 10:268-274.
2. Bligh, E.G. and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
3. Dudley, E., Yousef, M., Wang, Y., and Griffiths, W.J. 2010. Targeted metabolomics and mass spectrometry. Adv. Protein Chem. Struct. Biol. 80:45-83.
4. Dunn, W.B., Broadhurst, D.I., Atherton, H.J., Goodacre, R., and Griffin, J.L. 2011. Systems level studies of mammalian metabolomes: The roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40:387-426.
5. Festa, A., Williams, K., Hanley, A.J., Otvos, J.D., Goff, D.C., Wagenknecht, L.E., and Haffner, S.M. 2005 Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111:3465-3472.
6. Fiehn, O. 2001. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics. 2:155-168.
7. Forster, J., Famili, I., Fu, P., Palsson, B.O., and Nielsen, J. 2003. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res. 13:244-253.
8. Gerszten, R.E. and Wang, T.J. 2008. The search for new cardiovascular biomarkers. Nature 451:949-952.
9. Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.W., Wichmann, H.-E., Weinberger, K.M., Adamski, J., Illig, T., and Suhre, K. 2008. Genetics meets metabolomics: A genome-wide association study of metabolite profiles in human serum. PLOS Genet. 4:e1000282
10. Godovac-Zimmermann, J. and Brown, L.R. 2001. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom. Rev. 20:1-57.
11. Goodacre, R. 2003. Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Kluwer Academic Publishers, London.
12. Goodacre, R., Vaidyanathan, S., Dunn,W.B., Harrigan, G.G., andKell, D.B. 2004 Metabolomics by numbers: Acquiring and understanding global metabolite data. Trends Biotechnol. 22:245-252.
13. Griffin, J.L. 2006. TheCinderella story of metabolic profiling: Does metabolomics get to go to the functional genomics ball? Philos. Trans. R Soc. Lond. B Biol. Sci. 361:147-161.
14. Griffin, J.L., Nicholls, A.W., Keun, H.C., Mortishire-Smith, R.J., Nicholson, J.K., and Kuehn, T. 2002. Metabolic profiling of rodent biological fluids via 1H NMR spectroscopy using a 1 mm microlitre probe. Analyst 127:582-584.
15. Griffin, J.L., Cemal, C.K., and Pook, M.A. 2004. Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Physiol. Genomics 16:334-340.
16. Griffiths, J.R., McSheehy, P.M., Robinson, S.P., Troy, H., Chung, Y.L., Leek, R.D., Williams, K.J., Stratford, I.J., Harris, A.L., and Stubbs,M. 2002. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wildtype tumours deficient in hypoxia-inducible factor-1β (HIF-1β): Evidence of an anabolic role for the HIF-1 pathway. Cancer Res. 62:688-695.
17. Han,X., Holtzman, D.M.,McKeel,D.W. Jr.,Kelley, J., and Morris, J.C. 2002. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis. J. Neurochem. 82:809-818.
18. Knochenmuss, R. 2003. A quantitative model of ultraviolet matrix-assisted laser desorption/ ionization including analyte ion generation. Anal. Chem. 75:2199-2207.
19. Lewis, G.D., Farrell, L., Wood, M.J., Martinovic, M.,Arany, Z., Rowe, G.C., Souza, A.,Cheng, S., McCabe, E.L., Yang, E., Shi, X., Deo, R., Roth, F.P., Asnani, A., Rhee, E.P., Systrom, D.M., Semigran, M.J., Vasan, R.S., Carr, S.A., Wang, T.J., Sabatine, M.S., Clish, C.B., and Gerszten, R.E. 2010. Metabolic signatures of exercise in human plasma. Sci. Trans. Med. 2:33ra37.
20. Lindon, J.C.,Holmes, E., and Nicholson, J.K. 2003. So what's the deal with metabonomics? Anal. Chem. 75:384A-391A.
21. Masson, P., Couto Alves, A., Ebbels, T.M.D., Nicholson, J.K., andWant, E.J. 2010. Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Anal. Chem. 82:7779-7786
22. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B.R., Yancy,W.S. Jr., Eisenson, H.,Musante, G., Surwit, R.S., Millington, D.S., Butler, M.D., and Svetkey, L.P. 2009. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9:311-326.
23. Nicholson, J.K., Lindon, J.C., and Holmes, E. 1998. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181-1189.
24. Odunsi, K.,Wollman,R.M., Ambrosone,C.B., Hutson, A., McCann, S.E., Tammela, J., Geisler, J.P., Miller, G., Sellers, T., Cliby, W., Qian, F., Keitz, B., Intengan, M., Lele, S., and Alderfer, J.L. 2005. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 113:782-788.
25. Oliver, S.G.,Winson, M.K.,Kell, D.B., and Baganz, F. 1998. Systematic functional analysis of the yeast genome. Trends Biotechnol. 16:373-378.
26. Oursel, D., Loutelier-Bourhis, C., Orange, N., Chevalier, S., Norris, V., and Lange, C.M. 2007. Identification and relative quantification of fatty acids in Escherichia coli membranes by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 21:3229-3233.
27. Panisko, E.A., Conrads, T.P., Goshe, M.B., and Veenstra, T.B. 2002. The postgenomic age: Characterization of proteomes. Exp. Hematol. 30:97-107.
28. Pauling, L., Robinson, A.B., Teranishi, R., and Cary, P. 1971. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl. Acad. Sci. U.S.A. 68:2374-2376.
29. Peterson, B.L. and Cummings, B.S. 2006. A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed. Chromatogr. 20:227-243.
30. Petkovic, M., Schiller, J., Muller, M., Benard, S., Reichl, S., Arnold, K., and Arnhold, J. 2001. Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry: Phosphatidylcholine prevents the detection of further species. Anal. Biochem. 289:202-216.
31. Roberts, L.D., McCombie, G., Titman, C.M., and Griffin, J.L. 2008. A matter of fat: An introduction to lipidomic profiling methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871:174-181.
32. Roberts, L.D., Murray, A.J., Menassa, D., Ashmore, T., Nicholls, A.W., and Griffin, J.L. 2011. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol. 12:R75.
33. Sellick, C.A., Knight, D., Croxford, A.S., Maqsood, A.R., Stephens, G.M.,Goodacre, R., and Dickson, A.J. 2010. Evaluation of extraction processes for intracellular metabolite profiling of mammalian cells: Matching extraction approaches to cell type and metabolite targets. Metabolomics 6:427-438.
34. Spencer, F., Lagarde, M., Geloen, A., and Record, M. 2003. What is lipidomics? Eur. J. Lipid Sci. Technol. 105:481-482.
35. Wakelam, M.J., Pettitt, T.R., and Postle, A.D. 2007. Lipidomic analysis of signaling pathways. Methods Enzymol. 432:233-246.
36. Wang, C., Kong, H., Guan, Y., Yang, J., Gu, J., Yang, S., and Xu, G. 2005. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetesmellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal. Chem. 77:4108-4116.
37. Wang, T.J., Larson, M.G., Vasan, R.S., Cheng, S., Rhee, E.P.,McCabe, E., Lewis, G.D., Fox, C.S., Jacques, P.F., Fernandez, C., O'Donnell, C.J., Carr, S.A., Mootha, V.K., Florez, J.C., Souza, A., Melander, O., Clish, C.B., and Gerszten, R.E. 2011. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17:448-453.
38. Wenk, M.R. 2005. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4:594-610.
39. Wishart, D.S. 2011. Advances in metabolite identification. Bioanalysis 3:1769-1782.
40. Xia, J., Psychogios, N., Young, N., and Wishart, D.S. 2009. MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37:W652-W660.
41. Yu Lin, C., Wu, H., Tjeerdema, R.S., and Viant, M.R. 2007. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3:55-67.